ObsEva (NASDAQ:OBSV) Research Coverage Started at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of ObsEva (NASDAQ:OBSV) in a report released on Sunday. The firm set a “hold” rating on the stock.

ObsEva Stock Performance

Shares of NASDAQ:OBSV opened at $0.01 on Friday. The company has a market cap of $389,855.00, a price-to-earnings ratio of -0.01 and a beta of 0.68. ObsEva has a 12 month low of $0.08 and a 12 month high of $2.14. The company has a 50-day moving average price of $0.02 and a 200 day moving average price of $0.04.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.